您好,欢迎来到试剂信息网! [登录] [免费注册]
试剂信息网
位置:首页 > 产品库 > Linoleoyl Ethanolamide-d4
立即咨询
咨询类型:
     
*姓名:
*电话:
*单位:
Email:
*留言内容:
请详细说明您的需求。
*验证码:
 
Linoleoyl Ethanolamide-d4
本产品不向个人销售,仅用作科学研究,不用于任何人体实验及非科研性质的动物实验。
Linoleoyl Ethanolamide-d4图片
CAS NO:1451194-69-6
包装与价格:
包装价格(元)
100 μg电议
500 μg电议
1mg电议
5mg电议

产品介绍
An internal standard for the quantification of linoleoyl ethanolamide
Cas No.1451194-69-6
Canonical SMILESO=C(NC([2H])([2H])C([2H])([2H])O)CCCCCCC\C=C/C/C=C\CCCCC
分子式C20H33D4NO2
分子量327.5
溶解度DMF: 25 mg/ml,DMSO: 25 mg/ml,Ethanol: 50 mg/ml,Ethanol:PBS (pH 7.2)(1:2): 100 μg/ml
储存条件Store at -20°C
General tipsFor obtaining a higher solubility , please warm the tube at 37 ℃ and shake it in the ultrasonic bath for a while.
Shipping ConditionEvaluation sample solution : ship with blue ice
All other available size: ship with RT , or blue ice upon request
产品描述

Linoleoyl ethanolamide-d4contains four deuterium atoms at the hydroxyethyl 1,1',2, and 2' positions. It is intended for use as an internal standard for the quantification of linoleoyl ethanolamide by GC-or LC-mass spectrometry. Linoleoyl ethanolamide is an endocannabinoid detected in porcine brain and murine peritoneal macrophages which contains linoleate in place of the arachidonate moiety of arachidonoyl ethanolamide (AEA).1,2It has weak affinity for the central cannabinoid (CB1) and peripheral cannabinoid (CB2) receptors, exhibiting Kivalues of 10 µM and 25 µM, respectively.3However, it is only approximately 4-fold less potent than AEA at causing catalepsy in mice (ED50of 26.5 mg/kg).4In addition, linoleoyl ethanolamide increases ERK phosphorylation and AP-1-dependent transcription approximately 1.5-fold at 15 µM in a CB-receptor-independent manner.5However, cellular toxicity is readily apparent at concentrations of 10-20 µM. Linoleoyl ethanolamide inhibits human fatty acid amide hydrolase-dependent hydrolysis of AEA with a Kivalue of 9.0 µM, but also is hydrolyzed effectively by the enzyme.6,7

1.Patrono, C., Rotella, C.M., Toccafondi, R.S., et al.Prostacyclin stimulates the adenylate cyclase system of human thyroid tissueProstaglandins22(1)105-115(1981) 2.Schmid, P.C., Kuwae, T., Krebsbach, R.J., et al.Anandanide and other N-acylethanolamines in mouse peritoneal macrophagesChemistry and Physics of Lipids87103-110(1997) 3.Lin, S., Khanolkar, A.D., Fan, P., et al.Novel analogues of arachidonylethanolamide (anandamide): Affinities for the CB1 and CB2 cannabinoid receptors and metabolic stabilityJournal of Medicinal Chemistry415353-5361(1998) 4.Watanabe, K., Matsunaga, T., Nakamura, S., et al.Pharmacological effects in mice of anandamide and its related fatty acid ethanolamides, and enhancement of cataleptogenic effect of anandamide by phenylmethylsulfonyl fluorideBiological and Pharmaceutical Bullentin22(4)366-370(1999) 5.Berdyshev, E.V., Schmid, P.C., Krebsbach, R.J., et al.Cannabinoid-receptor-independent cell signalling by N-acylethanolaminesBiochemistry Journal36067-75(2001) 6.Maccarrone, M., van der Stelt, M., Rossi, A., et al.Anandamide hydrolysis by human cells in culture and brainThe Journal of Biological Chemisty27332332-32339(1998) 7.Bisogno, T., Maurelli, S., Melck, D., et al.Biosynthesis, uptake, and degradation of anandamide and palmitoylethanolamide in leukocytesThe Journal of Biological Chemisty2723315-3323(1997)